Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

“Turf Wars” Hinder Development Of Carotid Stenting Guidelines – TCT Docs

This article was originally published in The Gray Sheet

Executive Summary

CMS is calling on interventionalists, radiologists and surgeons to collaborate on carotid stenting training and credentialing requirements

You may also be interested in...



CMS Backs Limited Carotid Stent Coverage Expansion, Mulls Criteria For Docs

CMS is soliciting comments on standards and evaluation criteria for physicians and facilities performing carotid artery stenting procedures (CAS)

CMS Backs Limited Carotid Stent Coverage Expansion, Mulls Criteria For Docs

CMS is soliciting comments on standards and evaluation criteria for physicians and facilities performing carotid artery stenting procedures (CAS)

Holiday plan for carotid stent coverage

Medicare national coverage would extend to carotid stent patients at high risk in surgery, and who experience "symptomatic narrowing of the carotid artery of 70% or more," according to CMS' Dec. 17 proposal. In October, Medicare initiated coverage of the technology for FDA-required, post-approval studies (1"The Gray Sheet" Oct. 11, 2004, p. 5). Effective immediately, CMS also will expand insulin pump coverage for diabetics...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT021024

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel